ORBi: Detailled Reference

Article (Scientific journals)

La chirurgie metabolique, vers une (r)evolution de la chirurgie bariatrique ?

SCHEEN, André; DE FLINES, Jenny; RORIVE, Marcelle et al.

2011 • In Revue Médicale de Liège, 66 (4), p. 183-90

Peer reviewed

Permalink
https://hdl.handle.net/2268/99489

PubMed
21638835

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

3. SCHEEN Chirmeta (8).pdf

Publisher postprint (601.83 kB)

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

Bariatric Surgery; Diabetes Mellitus, Type 2/surgery; Humans

Abstract :

[en] Bariatric surgery has proven its efficacy to obtain a marked and sustained weight loss and dramatically improves metabolic control in obese patients. The frequently observed remission of type 2 diabetes occurs very early, before any marked weight reduction. Increasing evidence suggests that this favourable effect results from profound changes in gut hormones involved in the regulation of energy intake behaviour and glucose homeostasis rather than simply from mechanical food restriction or malabsorption imposed by the surgical procedure. The better knowledge of these pathophysiological mechanisms, especially well studied with Roux-en Y gastric bypass, resulted in recent innovation in the technical procedures leading to a shift from bariatric surgery to metabolic surgery. Such type of surgery is currently evaluated in patients with type 2 diabetes, but with only a moderate obesity (BMI < 35 kg/m2), or even without obesity (BMI < 30 kg/m2). The Belgian Metabolic Intervention (BMI) Study Group would like to contribute very soon to this evaluation in a multidisciplinary approach.

Disciplines :

Endocrinology, metabolism & nutrition
Surgery

Author, co-author :

SCHEEN, André ; Centre Hospitalier Universitaire de Liège - CHU > Diabétologie,nutrition, maladies métaboliques

DE FLINES, Jenny ; Centre Hospitalier Universitaire de Liège - CHU > Diabétologie,nutrition, maladies métaboliques

RORIVE, Marcelle ; Centre Hospitalier Universitaire de Liège - CHU > Diabétologie,nutrition, maladies métaboliques

DE ROOVER, Arnaud ; Centre Hospitalier Universitaire de Liège - CHU > Chirurgie abdominale- endocrinienne et de transplantation

Paquot, Nicolas ; Centre Hospitalier Universitaire de Liège - CHU > Diabétologie,nutrition, maladies métaboliques

Language :

French

Title :

La chirurgie metabolique, vers une (r)evolution de la chirurgie bariatrique ?

Alternative titles :

[en] Metabolic surgery: an evolution (or revolution) of bariatric surgery?

Publication date :

2011

Journal title :

Revue Médicale de Liège

ISSN :

0370-629X

eISSN :

2566-1566

Publisher :

Université de Liège. Revue Médicale de Liège, Liège, Belgium

Volume :

66

Issue :

4

Pages :

183-90

Peer reviewed :

Peer reviewed

Available on ORBi :

since 01 October 2011

Statistics

Number of views

483 (14 by ULiège)

Number of downloads

937 (16 by ULiège)

More statistics

Scopus citations^®

7

Scopus citations^®
without self-citations

1

Bibliography

Desaive C, Gerard J. - La gastroplastie dans le traitement de l'obésité morbide. Rev Med Liège, 1987, 42, 955-958.
Belachew M, Desiron Q, Messens D. - Traitement chirurgical de l'obesité morbide. Place de la gastroplastie. Rev Med Liège, 1992, 47, 1-9.
Scheen AJ. - Place de la chirurgie bariatrique dans le traitement de l'obésité. In : Traité de Diabétologie, 2e édition(Ed : Grimaldi A.), Médecine-Sciences Flammarion, Paris, France, 2009, 387-394.
Colquitt JL, Picot J, Loveman E, Cleqq AJ. - Surgery for obesity. Cochrane Database Syst Rev, 2009, 2, CD003641.
Rorive M, De Flines J, Paquot N, et al. - Actualités thérapeutiquesdans le domaine de l'obésité. Rev Med Liège, 2007, 62, 329-334.
National Institutes of Health Consensus Development Panel. - Gastrointestinal surgery for severe obesity. Consensus Development Conference Statement. Ann Intern Med, 1991, 115, 956-961.
Fried M, Hainer V, Basdevant A, et al. - Interdisciplinary European guidelines for surgery for severe (morbid) obesity. Obes Surg, 2007, 17, 260-270. (Pubitemid 47091559)
Scheen AJ, De Flines J, De Roover A, Paquot N. - Bariatric surgery in patients with Type 2 diabetes : benefits, risks, indications and perspectives. Diabetes Metab, 2009, 35, 537-543.
Buchwald H, Estok R, Fahrbach H, et al. - Weight and type 2 diabetes after bariatric surgery : systematic review and meta-analysis. Am J Med, 2009, 122, 248-256.
Scheen AJ. - Aggressive weight reduction treatment in the management of type 2 diabetes. Diab Metab, 1998, 23, 116-123. (Pubitemid 28239808)
Luyckx FH, Scheen AJ, Desaive C, et al. - Effects of gastroplasty on body weight and related biological abnormalities in morbid obesity. Diabetes Metab, 1998, 24, 355-361. (Pubitemid 28453162)
De Flines J, Letiexhe MR, Desaive C, Scheen AJ. - L'histoire naturelle d'une obésité morbide : aller vers le diabètede type 2 insulinorequérant et retour après chirurgie bariatrique. Rev Med Liège, 2001, 56, 816-822.
Thaler JP, Cummings DE. - Minireview : hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology, 2009, 150, 2518-2525.
Rubino F, R'bibo SL, del Genio F, et al. - Metabolic surgery : the role of the gastrointestinal tract in diabetes mellitus. Nat Rev Endocrinol, 2010, 6, 102-109.
Karra E, Yousseif A, Batterham RL. - Mechanisms facilitating weight loss and resolution of type 2 diabetes following bariatric surgery. Trends Endocrinol Metab, 2010, 21, 337-344.
Scheen AJ, De Flines J, De Roover A, Paquot N. - Le tractus digestif comme organe endocrine : une nouvelle vision de la chirurgie bariatrique. Méd Mal Metabol, 2011, 5, sous presse.
Scheen AJ, De Flines J, De Roover A, Paquot N. - De la chirurgie bariatrique à la chirurgie métabolique : vers un nouveau paradigme dans le traitement du diabète de type 2. Méd Mal Metabol, 2011, 5, sous presse.
Garweg C, Scholtes F, Gerard J, Wahlen C. - Ghréline et obésité. Rev Med Liège, 2005, 60, 35-40.
Lee H, Te C, Koshy S, et al. - Does ghrelin really matter after bariatric surgery? Surg Obes Relat Dis, 2006, 20, 538-548. (Pubitemid 44464088)
Tymitz K, Engel A, McDonough S, et al. - Changes in ghrelin levels following bariatric surgery : review of the literature. Obes Surg, 2011, 21, 125-130.
Heppner KM, Tong J, Kirchner H, et al. - The ghrelin O-acyltransferase- ghrelin system: a novel regulator of glucose metabolism. Curr Opin Endocrinol Diabetes Obes, 2010, 18, 50-55.
Rodieux F, Giusti V, D'Alessio DA, et al. - Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release. Obesity (Silver Spring), 2008, 16, 298-305. (Pubitemid 351271908)
Langer FB, Reza Hoda MA, Bohdjalian A, et al. - Sleeve gastrectomy and gastric banding : effects on plasma ghrelin levels. Obes Surg, 2005, 15, 1024-1029. (Pubitemid 41116888)
Karamanakos SN, Vagenas K, Kalfarentzos F, Alexandrides TK. - Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy : a prospective, double blind study. Ann Surg, 2008, 247, 401-407.
Bohdjalian A, Langer FB, Shakeri-Leidenmühler S, et al. - Sleeve gastrectomy as sole and definitive bariatric procedure : 5-year results for weight loss and ghrelin. Obes Surg, 2010, 20, 535-540.
Pories WJ, MacDonald KG Jr, Flickinger EG, et al. - Etiology of type II diabetes mellitus : role of the foregut. World J Surg, 2001, 25, 527-531. (Pubitemid 32455209)
Rubino F, Forgione A, Cummings DE, et al. - The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg, 2006, 244, 741-749. (Pubitemid 44629948)
Andreelli F, Amouyal C, Magnan C, Mithieux G. - What can bariatric surgery teach us about the pathophysiology of type 2 diabetes? Diabetes Metab, 2009, 35, 499-507.
Knop FK. - Resolution of type 2 diabetes following gastric bypass surgery: involvement of gut-derived glucagon and glucagonotropic signalling ? Diabetologia, 2009, 52, 2270-2276.
Lin E, Davis SS, Srinivasan J, et al. - Dual mechanism for type-2 diabetes resolution after Roux-en-Y gastric bypass. Am Surg, 2009, 75, 498-502.
Marceau P, Biron S, Hould FS, et al. - Duodenal switch: long-term results. Obes Surg, 2007, 17, 1421-1430.
Gutierrez-Aguilar R, Woods SC. - Nutrition and L and K- enteroendocrine cells. Curr Opin Endocrinol Diabetes Obes, 2011, 18, 35-41.
Rao RS, Kini S. - GIP and bariatric surgery. Obes Surg, 2011, 21, 244-252.
Scheen AJ. - Le glucagon-like peptide-1 (GLP-1), nouvelle cible dans le traitement du diabète de type 2. Rev Med Liège, 2007, 62, 216-219.
Laferrère B. - Effect of gastric bypass surgery on the incretins. Diabetes Metab, 2009, 35, 513-517.
Bose M, Oliván B, Teixeira J, et al. - Do incretins play a role in the remission of type 2 diabetes after gastric bypass surgery : What are the evidence? Obes Surg, 2009, 19, 217-229.
Kashyap SR, Daud S, Kelly KR, et al. - Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes. Int J Obes (Lond), 2010, 34, 462-471.
Ballantyne GH. - Peptide YY(1-36) and peptide YY(3-36): Part II. Changes after gastrointestinal surgery and bariatric surgery. Obes Surg, 2006, 16, 795-803. (Pubitemid 43874841)
Valderas JP, Irribarra V, Boza C, et al. - Medical and surgical treatments for obesity have opposite effects on peptide YY and appetite : a prospective study controlled for weight loss. J Clin Endocrinol Metab, 2010, 95, 1069-1075.
Bose M, Machineni S, Oliván B, et al. - Superior appetitehormone profile after equivalent weight loss by gastric bypass compared to gastric banding. Obesity (Silver Spring), 2010, 18, 1085-1091.
Wynne K, Field BC, Bloom SR. - The mechanism of action for oxyntomodulin in the regulation of obesity. Curr Opin Investig Drugs, 2010, 11, 1151-1157.
Laferrère B, Swerdlow N, Bawa B, et al. - Rise of oxyntomodulin in response to oral glucose after gastric bypass surgery in patients with type 2 diabetes. J Clin Endocrinol Metab, 2010, 95, 4072-4076.
Strader AD. - Ileal transposition provides insight into the effectiveness of gastric bypass surgery. Physiol Behav, 2006, 88, 277-282. (Pubitemid 44202216)
Rubino F, Kaplan LM, Schauer PR, Cummings DE. - The diabetes surgery summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus. Ann Surg, 2010, 251, 399-405.
Fried M, Ribaric G, Buchwald JN, et al. - Metabolic surgery for the treatment of type 2 diabetes in patients with BMI < 35 kg/m2 : an integrative review of early studies. Obes Surg, 2010, 20, 776-790.
Schulman AP, Del Genio F, Sinha N, Rubino F. - Metabolic surgery for the treatment of type 2 diabetes. Endocr Pract, 2009, 15, 624-631.
Cohen R, Pinheiro JS, Correa JL, Schiavon CA. - Laparoscopic Roux-en Y gastric bypass for BMI < 35 kg/m2: a tailored approach. Surg Obesity Relat Dis, 2006, 2, 401-404. (Pubitemid 43812096)
Lee W-J, Wang W, Lee Y-C, et al. - Effect of laparo-scopic mini-gastric bypass for type 2 diabetes mellitus: comparison of BMI>35 and <35 kg/m2. J Gastrointest Surg, 2008, 12, 945-952.
Shah SS, Todkar JS, Shah PS, Cummings DE. - Diabetes remission and reduced cardiovascular risk after gastric bypass in Asian Indians with body mass index <35 kg/m2. Surg Obes Relat Dis, 2010, 6, 332-338.
Demaria EJ, Winegar DA, Pate VW, et al. - Early postoperative outcomes of metabolic surgery to treat diabetes from sites participating in the ASMBS bariatric surgery center of excellence program as reported in the Bariatric Outcomes Longitudinal Database. Ann Surg, 2010, 252, 559-566.
Cohen RV, Schiavon CA, Pinheiro JS, et al. - Duodenal-jejunal bypass for the treatment of type 2 diabetes in patients with body mass index of 22-34 kg/m2 : a report of 2 cases. Surg Obes Relat Dis, 2007, 3, 195-197. (Pubitemid 46444706)
Geloneze B, Geloneze SR, Fiori C, et al. - Surgery for nonobese type 2 diabetic patients : an interventional study with duodenal-jejunal exclusion. Obes Surg, 2009, 19, 1077-1083.
Ramos AC, Galvao Neto MP, de Souza YM, et al. - Laparoscopic duodenaljejunal exclusion in the treatment of type 2 diabetes mellitus in patients with BMI <30 kg/m2. Obes Surg, 2009, 19, 307-312.
Ferzli GS, Dominique E, Ciaglia M, et al. - Clinical improvement after duodenojejunal bypass for nonobese type 2 diabetes despite minimal improvement in glycemic homeostasis. World J Surg, 2009, 33, 972-979.
Rodriguez L, Reyes E, Fagalde P, et al. - Pilot clinical study of an endoscopic, removable duodenal-jejunal bypass liner for the treatment of type 2 diabetes. Diabetes Technol Ther, 2009, 11, 725-732.
Gagner M. - La transposition iléale avec ou sans gastrectomiepar laparoscopie chez l'homme (TIG) : la troisième génération de chirurgie bariatrique. J Coeliochirurgie,2005, 54, 4-10.
DePaula AL, Macedo AL, Rassi N, et al. - Laparo-scopic treatment of type 2 diabetes mellitus for patients with a body mass index less than 35. Surg Endosc, 2008, 22, 706-716. (Pubitemid 351341683)
DePaula AL, Macedo AL, Mota BR, Schraibman V. - Laparoscopic ileal interposition associated to a diverted sleeve gastrectomy is an effective operation for the treatment of type 2 diabetes mellitus patients with BMI 21-29. Surg Endosc, 2009, 23, 1313-1320.
DePaula AL, Macedo AL, Schraibman V, et al. - Hormonal evaluation following laparoscopic treatment of type 2 diabetes mellitus patients with BMI 20-34. Surg Endosc, 2009, 23, 1724-1732.
De Paula AL, Stival AR, Macedo A, et al. - Prospective randomized controlled trial comparing 2 versions of laparoscopic ileal interposition associated with sleeve gastrectomy for patients with type 2 diabetes with BMI 21-34 kg/m(2). Surg Obes Relat Dis, 2010, 6, 296-304.
Kumar KV, Ugale S, Gupta N, et al. - Ileal interposition with sleeve gastrectomy for control of type 2 diabetes. Diabet Technol Ther, 2009, 11, 785-789.
Depaula AL, Stival A, Halpern A, Vencio S. - Thirty-day morbidity and mortality of the laparoscopic ileal interposition associated with sleeve gastrectomy for the treatment of type 2 diabetic patients with BMI <35 : an analysis of 454 consecutive patients. World J Surg, 2011, 35, 102-108.
Pories WJ, MacDonald KG, Flickinger EG, et al. - Is type II diabetes mellitus (NIDDM) a surgical disease? Ann Surg, 1992, 215, 633-643.
Pories WJ, Swanson MS, MacDonald KG, et al. - Who would have thought it ? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg, 1995, 222, 339-352.
Rubino F. - Is type 2 diabetes an operable intestine disease ? A provocative yet reasonable hypothesis. Diabetes Care, 2008, 31, S290-S296.
Purnell JQ, Flum DR.- Bariatric surgery and diabetes: who should be offered the option of remission? JAMA, 2009, 301, 1593-1595.
International Diabetes Federation. - Bariatric surgical and procedural interventions in the treatment of obese patients with type 2 diabetes. A position statement from International Diabetes Federation Task Force on Epidemiology and Prevention, 2011, 39 p.
Deitel M. - Surgery for diabetes at lower BMI : some caution. Obes Surg, 2008, 18, 1211-1214.
Giusti V. - Chirurgie du diabète : provocation ou réalité?Rev Med Suisse, 2010, 6, 670-4, 676.

Similar publications